You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nivolumab

Showing 26 - 50 of 1,700
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma of the Head and Neck, Paclitaxel, Carboplatin Trial in Amiens (GCP intratumoral catheter)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +3 more
  • intratumoral catheter
  • Amiens, Picardie, France
    CHU Amiens Picardie
Apr 26, 2023

Advanced Metastatic Cancer, Advanced Prostate Cancer Trial in United States (Nivolumab Monotherapy, Nivolumab and Ipilimumab and

Active, not recruiting
  • Advanced Metastatic Cancer
  • Advanced Prostate Cancer
  • Nivolumab Monotherapy
  • +3 more
  • Los Angeles, California
  • +5 more
Dec 16, 2022

Pancreatic Cancer Trial in Herlev (drug, radiation, biological)

Not yet recruiting
  • Pancreatic Cancer
  • Nivolumab
  • +3 more
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Feb 8, 2023

Hepatocellular Carcinoma Trial in Philadelphia (Abemaciclib, Nivolumab)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 17, 2022

Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab

Recruiting
  • Metastatic Gastric Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Nivolumab Injection
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Aug 23, 2023

Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)

Recruiting
  • Metastatic Melanoma
  • Metastasis to Brain
  • Nivolumab
  • +3 more
  • Tampa, Florida
  • +1 more
Jan 30, 2023

Cervical Cancer = FIGO IIB and or Lymph Node Metastases Trial (Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab),

Not yet recruiting
  • Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases
  • Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab)
  • +2 more
  • (no location specified)
Aug 16, 2022

Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Feb 1, 2023

Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))

Active, not recruiting
  • Merkel Cell Carcinoma
  • Skin Cancer
  • Nivolumab
  • +2 more
  • Tampa, Florida
  • +1 more
Nov 11, 2022

Advanced Solid Tumors Trial in Canada, United States (BMS-986408, Nivolumab, Ipilimumab)

Recruiting
  • Advanced Solid Tumors
  • Boston, Massachusetts
  • +5 more
Jan 10, 2023

Hodgkin Lymphoma Trial in Moscow (Nivolumab)

Recruiting
  • Hodgkin Lymphoma
  • Nivolumab
  • Moscow, Russian Federation
    National Research Center for Hematology
Dec 13, 2022

IDH1-mutant Cholangiocarcinoma Trial (Ivosidenib, Recommended Combination Dose (RCD) of ivosidenib, Nivolumab)

Not yet recruiting
  • IDH1-mutant Cholangiocarcinoma
  • (no location specified)
Jun 29, 2023

Endometrial Tumors, Endometrial Cancer Trial in Seoul (Nivolumab)

Not yet recruiting
  • Endometrial Neoplasms
  • Endometrial Cancer
  • Nivolumab
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Mar 21, 2023

Solid Carcinoma Trial (fecal microbiota transplantation with Nivolumab)

Not yet recruiting
  • Solid Carcinoma
  • fecal microbiota transplantation with Nivolumab
  • (no location specified)
Sep 14, 2022

Carcinoma, Hepatocellular, Hepatoma Trial in Seongnam, Seoul (Regorafenib/Nivolumab)

Completed
  • Carcinoma, Hepatocellular
  • Hepatoma
  • Seongnam, Korea, Republic of
  • +2 more
Dec 4, 2022

Diffuse Large B Cell Lymphoma Trial in Philadelphia (Nivolumab, IV, 240 mg)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Nivolumab, IV, 240 mg
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 3, 2023

Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)

Recruiting
  • Epstein-Barr Virus Infections
  • +3 more
  • Nivolumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Amsterdam (Irreversible Electroporation (IRE), Nivolumab, Toll-Like

Recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Irreversible Electroporation (IRE)
  • +2 more
  • Amsterdam, North-Holland, Netherlands
    Amsterdam University Medical Centre (location VUmc)
Dec 18, 2022

Metastatic Pancreatic Cancer Trial in Bern, Basel, Zürich (Nivolumab)

Recruiting
  • Metastatic Pancreatic Cancer
  • Nivolumab
  • Bern, BE, Switzerland
  • +2 more
Nov 15, 2022

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Trial (Nivolumab, Ipilimumab, Surgical Procedure)

Not yet recruiting
  • Pleural Biphasic Mesothelioma
  • Pleural Sarcomatoid Mesothelioma
  • Nivolumab
  • +5 more
  • (no location specified)
Dec 9, 2022

Peripheral T Cell Lymphoma Trial in Duarte, Aurora, Philadelphia (Nivolumab and EPOCH)

Active, not recruiting
  • Peripheral T Cell Lymphoma
  • Nivolumab and EPOCH
  • Duarte, California
  • +2 more
Jan 6, 2023

Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

Not yet recruiting
  • Metastatic Extraskeletal Myxoid Chondrosarcoma
  • +3 more
  • Biopsy
  • +6 more
  • (no location specified)
Apr 25, 2023

Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

Recruiting
  • Non-Clear Cell Renal Cell Carcinoma
  • Duarte, California
    Exelixis Clinical Site #1
Jan 13, 2023

NSCLC Trial in Worldwide (BMS-986315, Nivolumab, Pemetrexed)

Not yet recruiting
  • NSCLC
  • Boise, Idaho
  • +12 more
Oct 17, 2023

Ovarian Cancer Trial in Houston (Nivolumab, Etigilimab)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023